These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 6102500)

  • 1. Pharmacokinetic and pharmacodynamic properties of metoprolol in patients with impaired renal function.
    Jordö L; Attman PO; Aurell M; Johansson L; Johnsson G; Regårdh CG
    Clin Pharmacokinet; 1980; 5(2):169-80. PubMed ID: 6102500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of impaired renal function on the plasma concentration and urinary excretion of metoprolol metabolites.
    Hoffmann KJ; Regårdh CG; Aurell M; Ervik M; Jordö L
    Clin Pharmacokinet; 1980; 5(2):181-91. PubMed ID: 7363533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of metoprolol in patients with hepatic cirrhosis.
    Regårdh CG; Jordö L; Ervik M; Lundborg P; Olsson R; Rönn O
    Clin Pharmacokinet; 1981; 6(5):375-88. PubMed ID: 7333059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of metoprolol and its metabolites in dialysis patients.
    Seiler KU; Schuster KJ; Meyer GJ; Niedermayer W; Wassermann O
    Clin Pharmacokinet; 1980; 5(2):192-8. PubMed ID: 7363534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of pretreatment with cimetidine on the bioavailability and disposition of atenolol and metoprolol.
    Houtzagers JJ; Streurman O; Regårdh CG
    Br J Clin Pharmacol; 1982 Jul; 14(1):67-72. PubMed ID: 6125199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels and effects of metoprolol on blood pressure and heart rate in hypertensive patients after an acute dose and between two doses during long-term treatment.
    Bengtsson C; Johnsson G; Regårdh CG
    Clin Pharmacol Ther; 1975 Apr; 17(4):400-8. PubMed ID: 235398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers.
    Luzier AB; Killian A; Wilton JH; Wilson MF; Forrest A; Kazierad DJ
    Clin Pharmacol Ther; 1999 Dec; 66(6):594-601. PubMed ID: 10613615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentrations and beta-blocking effects in normal volunteers after intravenous doses of metoprolol and propranolol.
    Regårdh CG; Johnsson G; Jordö L; Lungborg P; Persson BA; Rönn O
    J Cardiovasc Pharmacol; 1980; 2(6):715-23. PubMed ID: 6160322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels and beta-blocking effect of alpha-hydroxymetoprolol--metabolite of metoprolol--in the dog.
    Regårdh CG; Ek L; Hoffmann KJ
    J Pharmacokinet Biopharm; 1979 Oct; 7(5):471-9. PubMed ID: 43384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metoprolol kinetics and dose response in hypertensive patients.
    Myers MG; Thiessen JJ
    Clin Pharmacol Ther; 1980 Jun; 27(6):756-62. PubMed ID: 7379442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective metabolism of metoprolol in poor hydroxylators of debrisoquine.
    Lennard MS; Silas JH; Freestone S; Trevethick J
    Br J Clin Pharmacol; 1982 Aug; 14(2):301-3. PubMed ID: 6125207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and steady-state pharmacokinetics and antihypertensive effects of felodipine in patients with normal and impaired renal function.
    Larsson R; Karlberg BE; Gelin A; Aberg J; Regårdh CG
    J Clin Pharmacol; 1990 Nov; 30(11):1020-30. PubMed ID: 2243149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of oral talinolol following a single dose and during steady state in patients with chronic renal failure and healthy volunteers.
    Krueger M; Achenbach H; Terhaag B; Haase H; Richter K; Oertel R; Preiss R
    Int J Clin Pharmacol Ther; 2001 Feb; 39(2):61-6. PubMed ID: 11270803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug interaction between propafenone and metoprolol.
    Wagner F; Kalusche D; Trenk D; Jähnchen E; Roskamm H
    Br J Clin Pharmacol; 1987 Aug; 24(2):213-20. PubMed ID: 3620296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of beta blockers in heart failure.
    Talbert RL
    Heart Fail Rev; 2004 Apr; 9(2):131-7. PubMed ID: 15516861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ranitidine on the disposition of metoprolol.
    Kelly JG; Salem SA; Kinney CD; Shanks RG; McDevitt DG
    Br J Clin Pharmacol; 1985 Feb; 19(2):219-24. PubMed ID: 3986080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative pharmacokinetic profiles of metoprolol and chlorthalidone administered alone or in combination to healthy volunteers.
    Godbillon J; Gerardin A; John VA; Theobald W
    Eur J Clin Pharmacol; 1983; 24(5):655-60. PubMed ID: 6873146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Butofilolol pharmacokinetics in chronic renal insufficiency.
    Jeanniot JP; Houin G; Ledudal P; Cautreels W; Giudicelli CP; Tillement JP
    Int J Clin Pharmacol Res; 1984; 4(3):165-73. PubMed ID: 6149194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The single dose pharmacokinetics of bisoprolol (10 mg) in renal insufficiency: the clinical significance of balanced clearance.
    Payton CD; Fox JG; Pauleau NF; Boulton-Jones JM; Ioannides C; Johnston A; Thomas P
    Eur Heart J; 1987 Dec; 8 Suppl M():15-22. PubMed ID: 2897297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of carvedilol and metoprolol on regional vascular responses to adrenergic stimuli in normal subjects and patients with chronic heart failure.
    Hryniewicz K; Androne AS; Hudaihed A; Katz SD
    Circulation; 2003 Aug; 108(8):971-6. PubMed ID: 12912816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.